Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

MedImpact Healthcare Systems, the nation’s largest independent provider of health solutions, technology, and pharmacy benefit ...

India significantly contributes to global health security by providing essential generic and biosimilar medicines, which ...

Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...

Tariff worries prevailed as U.S. President Donald Trump ordered a probe into potential tariffs on copper imports to boost US production of the critical metal.

This initiative will support its second Alternative Investment Fund (AIF), Fund 2, by providing dry powder to capitalise on a ...

Revolt Motors, India’s No.1 electric motorcycle brand, has launched the all-new RV BlazeX - a high-performance, smart, and ...

The US FDA had conducted a current Good Manufacturing Practices inspection of Company's API manufacturing facility located at ...

India holds a two to three per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a global leader.